| Product Code: ETC7744297 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Japan continued to rely on imports of ophthalmology drugs and devices, with the USA, Germany, Ireland, Switzerland, and Sweden being the top exporting countries. Despite the low Herfindahl-Hirschman Index (HHI) indicating low market concentration, the industry experienced a negative Compound Annual Growth Rate (CAGR) of -3.16% from 2020 to 2024. Furthermore, the growth rate in 2024 saw a slight decline of -1.06% compared to the previous year. This data suggests a challenging market environment, possibly driven by factors such as regulatory changes or evolving consumer preferences.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Ophthalmology Drugs and Devices Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Ophthalmology Drugs and Devices Market - Industry Life Cycle |
3.4 Japan Ophthalmology Drugs and Devices Market - Porter's Five Forces |
3.5 Japan Ophthalmology Drugs and Devices Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.6 Japan Ophthalmology Drugs and Devices Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Japan Ophthalmology Drugs and Devices Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Japan Ophthalmology Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye disorders and diseases in Japan |
4.2.2 Technological advancements in ophthalmology drugs and devices |
4.2.3 Growing geriatric population in Japan requiring eye care services |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for ophthalmology drugs and devices |
4.3.2 High costs associated with advanced ophthalmology treatments |
4.3.3 Limited access to eye care services in certain regions of Japan |
5 Japan Ophthalmology Drugs and Devices Market Trends |
6 Japan Ophthalmology Drugs and Devices Market, By Types |
6.1 Japan Ophthalmology Drugs and Devices Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Diagnostic and Monitoring Devices, 2021- 2031F |
6.1.4 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Surgical Devices, 2021- 2031F |
6.1.5 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Vision Care, 2021- 2031F |
6.1.6 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2 Japan Ophthalmology Drugs and Devices Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Glaucoma, 2021- 2031F |
6.2.3 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Retinal disorders, 2021- 2031F |
6.2.4 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Dry eye, 2021- 2031F |
6.2.5 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Allergy/Inflammation/Conjunctivitis, 2021- 2031F |
6.3 Japan Ophthalmology Drugs and Devices Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Japan Ophthalmology Drugs and Devices Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Ophthalmology Drugs and Devices Market Import-Export Trade Statistics |
7.1 Japan Ophthalmology Drugs and Devices Market Export to Major Countries |
7.2 Japan Ophthalmology Drugs and Devices Market Imports from Major Countries |
8 Japan Ophthalmology Drugs and Devices Market Key Performance Indicators |
8.1 Average waiting time for ophthalmology treatment |
8.2 Percentage of population with access to eye care facilities |
8.3 Adoption rate of advanced ophthalmology drugs and devices |
8.4 Patient satisfaction with ophthalmology services |
8.5 Number of research and development initiatives in the ophthalmology sector |
9 Japan Ophthalmology Drugs and Devices Market - Opportunity Assessment |
9.1 Japan Ophthalmology Drugs and Devices Market Opportunity Assessment, By Products, 2021 & 2031F |
9.2 Japan Ophthalmology Drugs and Devices Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Japan Ophthalmology Drugs and Devices Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Japan Ophthalmology Drugs and Devices Market - Competitive Landscape |
10.1 Japan Ophthalmology Drugs and Devices Market Revenue Share, By Companies, 2024 |
10.2 Japan Ophthalmology Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here